Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Background Splenectomy and thrombopoietin receptor agonists (TPO-RAs) are recommended second-line therapies for immune thrombocytopenia. Although guidelines recommend tailoring second-line treatments to patient characteristics, this approach is often unclear in real-world practice. Objectives We examined claims-based time to next treatment (TTNT) and safety outcomes after splenectomy or TPO-RA as a second-line therapy using nationally representative Korean claims data. Methods Patients diagnosed with immune thrombocytopenia between 2002 and 2021 were included. From the eligible cohort, we identified patients whose index second-line treatment was splenectomy (group 1) or TPO-RA without prior splenectomy (group 2). Propensity score matching was performed between patients in both groups who had received corticosteroids as first-line treatment. Results After matching, 447 group 1 and 57 group 2 patients were analyzed. Subsequent treatment was administered to 82.3% and 61.4% of patients in groups 1 and 2, respectively. Median TTNTs were 5.80 and 3.03 months in groups 1 and 2, respectively. Estimated TTNT curves diverged after 24 months, with a longer TTNT observed in the TPO-RA group. Pneumococcal infections occurred in 3.1% of patients in group 1 and none in group 2. Venous thromboembolism (VTE) occurred in 10.5% and 15.7% of patients in groups 1 and 2, respectively. The observed time to VTE was shorter in group 2 than in group 1. Conclusion Patients treated with TPO-RAs as a second-line therapy showed a longer TTNT after 24 months, whereas VTE occurred earlier in the TPO-RA group. However, these findings should be interpreted with caution because of residual confounding.

키워드

immune thrombocytopenia; infections; splenectomy; thromboembolism; thrombopoietin receptor; agonist; treatment outcome; AMERICAN SOCIETY; TERM; PURPURA; GUIDELINES; MANAGEMENT; EFFICACY; ADULTS; ITP
제목
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
저자
Lim, Hyung-Jun; KWAK, Kunye; Kim, Changgon; Choi, Yoon Seok; Park, Yong; Kim, Byung Soo; Ahn, Ki Hoon; Kang, Ka-Won
DOI
10.1016/j.rpth.2026.106992
발행일
2026-10
유형
Article
저널명
Research and Practice in Thrombosis and Haemostasis
권
10
호
7